You are here

antibodies

Regeneron Antibody Cocktail a Priority for FDA with April Action Date

BioSpace

Fri, 10/15/21 - 12:35 pm

priority review

AstraZeneca's COVID-19 therapy hits goal in phase 3, but efficacy falls short of rivals

Fierce Biotech

Mon, 10/11/21 - 10:15 am

clinical trials

Women's COVID-19 antibody levels top men's after 2nd Pfizer shot, study finds

Beckers Hospital Review

Thu, 10/7/21 - 09:41 pm

AstraZeneca files for FDA green light of COVID-preventing antibody

Fierce Biotech

Tue, 10/5/21 - 10:36 am

Emergency Use Authorization

Amgen reveals midphase eczema data behind its $400M bet

Fierce Biotech

Mon, 10/4/21 - 10:38 am

clinical trials

Regeneron's COVID-19 antibody cocktail reduces hospitalization risk by 71%, study shows

Beckers Hospital Review

Sun, 10/3/21 - 08:39 pm

AstraZeneca is nearly ready to seek approval for its COVID-19 antibody. Can it stick the landing?

Fierce Biotech

Thu, 09/30/21 - 11:07 am

Boehringer Ingelheim acquires Abexxa Biologics

Biopharma Reporter

Tue, 09/21/21 - 10:56 am

Boehringer Ingelheim

Abexxa Biologics

drug development

FDA approves Eli Lilly antibody cocktail for COVID-19 prevention

Beckers Hospital Review

Thu, 09/16/21 - 11:10 pm

Emergency Use Authorization

Surging US demand triggers new $2.9B purchase of Regeneron's Covid-19 antibodies

Endpoints

Wed, 09/15/21 - 10:47 am

government contract

Moderna's Vaccine Is Said to Create More Antibodies Than Pfizer's

TheStreet.com

Tue, 08/31/21 - 10:51 am

Moderna Therapeutics

It's back: Eli Lilly's COVID-19 antibody combo makes its return after 2 months on the sidelines

Fierce Pharma

Mon, 08/30/21 - 10:59 am

bamlanivimab-etesevimab

Brii gets a Covid-19 antibody boost

EP Vantage

Wed, 08/25/21 - 11:09 am

Brii Biosciences

AstraZeneca antibody cocktail slashes risk of symptomatic COVID-19, setting up regulatory filings and a lifeline for the immunosuppressed

Fierce Biotech

Fri, 08/20/21 - 10:53 am

clinical trials

ExeVir doses first patients with llama-derived anti-Covid antibody

Endpoints

Wed, 08/18/21 - 10:55 am

clinical trials

Moderna's COVID-19 Vaccine Retains Antibodies Against Variants For 6 Months

Benzinga

Fri, 08/13/21 - 12:23 pm

Moderna Therapeutics

COVID-19 variants

Eli Lilly's COVID-19 antibody sales crater as variants, vaccines take a toll

Fierce Pharma

Tue, 08/3/21 - 11:08 am

FDA okays Regeneron COVID-19 antibody as preventive in high-risk settings

Yahoo/Reuters

Sat, 07/31/21 - 10:11 pm

Emergency Use Authorization

Amgen pays $900M for Teneobio and bets bigger on next-gen antibody drugs

BioPharma Dive

Wed, 07/28/21 - 07:22 pm

Boehringer takes alteplase to phase 3 for COVID, but drops antibody

Pharmaforum

Tue, 07/27/21 - 10:26 am

Boehringer Ingelheim

Pages